世界のタペンタドール市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV10487)
◆英語タイトル:Global Tapentadol Market Insights and Forecast to 2026
◆商品コード:QYR20NV10487
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:114
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはタペンタドールの世界市場について調査・分析した資料です。種類別(100mg錠、75mg錠、50mg錠)の市場規模、用途別(病院、診療所、薬局、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別タペンタドールの競争状況、市場シェア
・世界のタペンタドール市場:種類別市場規模 2015年-2020年(100mg錠、75mg錠、50mg錠)
・世界のタペンタドール市場:種類別市場規模予測 2021年-2026年(100mg錠、75mg錠、50mg錠)
・世界のタペンタドール市場:用途別市場規模 2015年-2020年(病院、診療所、薬局、その他)
・世界のタペンタドール市場:用途別市場規模予測 2021年-2026年(病院、診療所、薬局、その他)
・北米のタペンタドール市場分析:米国、カナダ
・ヨーロッパのタペンタドール市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのタペンタドール市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のタペンタドール市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのタペンタドール市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Johnson & Johnson Pharmaceutical Research & Development、IPCA Laboratories、Lupin Laboratories、Ranbaxy Laboratories、Aristo Pharmaceuticals、Cadila Pharmaceuticals、Tirupati Medicare
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Tapentadol is an analgesic with a dual mode of action as a norepinephrine reuptake inhibitor and an agonist of the mu-opioid receptor. Its analgesic properties come into effect within few minutes of oral administration.
North America is the largest market for tapentadol followed by Europe and Asia Pacific.

Market Analysis and Insights: Global Tapentadol Market
The global Tapentadol market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Tapentadol Scope and Market Size
Tapentadol market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tapentadol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Tapentadol market is segmented into
100 mg Tablets
75 mg Tablets
50 mg Tablets

Segment by Application, the Tapentadol market is segmented into
Hospital
Clinic
Pharmacy
Other

Regional and Country-level Analysis
The Tapentadol market is analysed and market size information is provided by regions (countries).
The key regions covered in the Tapentadol market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tapentadol Market Share Analysis
Tapentadol market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tapentadol business, the date to enter into the Tapentadol market, Tapentadol product introduction, recent developments, etc.

The major vendors covered:
Johnson & Johnson Pharmaceutical Research & Development
IPCA Laboratories
Lupin Laboratories
Ranbaxy Laboratories
Aristo Pharmaceuticals
Cadila Pharmaceuticals
Tirupati Medicare

【レポートの目次】

1 Study Coverage
1.1 Tapentadol Product Introduction
1.2 Market Segments
1.3 Key Tapentadol Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Tapentadol Market Size Growth Rate by Type
1.4.2 100 mg Tablets
1.4.3 75 mg Tablets
1.4.4 50 mg Tablets
1.5 Market by Application
1.5.1 Global Tapentadol Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Pharmacy
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Tapentadol Market Size, Estimates and Forecasts
2.1.1 Global Tapentadol Revenue 2015-2026
2.1.2 Global Tapentadol Sales 2015-2026
2.2 Global Tapentadol, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Tapentadol Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Tapentadol Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Tapentadol Competitor Landscape by Players
3.1 Tapentadol Sales by Manufacturers
3.1.1 Tapentadol Sales by Manufacturers (2015-2020)
3.1.2 Tapentadol Sales Market Share by Manufacturers (2015-2020)
3.2 Tapentadol Revenue by Manufacturers
3.2.1 Tapentadol Revenue by Manufacturers (2015-2020)
3.2.2 Tapentadol Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Tapentadol Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Tapentadol Revenue in 2019
3.2.5 Global Tapentadol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Tapentadol Price by Manufacturers
3.4 Tapentadol Manufacturing Base Distribution, Product Types
3.4.1 Tapentadol Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tapentadol Product Type
3.4.3 Date of International Manufacturers Enter into Tapentadol Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Tapentadol Market Size by Type (2015-2020)
4.1.1 Global Tapentadol Sales by Type (2015-2020)
4.1.2 Global Tapentadol Revenue by Type (2015-2020)
4.1.3 Tapentadol Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tapentadol Market Size Forecast by Type (2021-2026)
4.2.1 Global Tapentadol Sales Forecast by Type (2021-2026)
4.2.2 Global Tapentadol Revenue Forecast by Type (2021-2026)
4.2.3 Tapentadol Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tapentadol Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Tapentadol Market Size by Application (2015-2020)
5.1.1 Global Tapentadol Sales by Application (2015-2020)
5.1.2 Global Tapentadol Revenue by Application (2015-2020)
5.1.3 Tapentadol Price by Application (2015-2020)
5.2 Tapentadol Market Size Forecast by Application (2021-2026)
5.2.1 Global Tapentadol Sales Forecast by Application (2021-2026)
5.2.2 Global Tapentadol Revenue Forecast by Application (2021-2026)
5.2.3 Global Tapentadol Price Forecast by Application (2021-2026)

6 North America
6.1 North America Tapentadol by Country
6.1.1 North America Tapentadol Sales by Country
6.1.2 North America Tapentadol Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Tapentadol Market Facts & Figures by Type
6.3 North America Tapentadol Market Facts & Figures by Application

7 Europe
7.1 Europe Tapentadol by Country
7.1.1 Europe Tapentadol Sales by Country
7.1.2 Europe Tapentadol Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tapentadol Market Facts & Figures by Type
7.3 Europe Tapentadol Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Tapentadol by Region
8.1.1 Asia Pacific Tapentadol Sales by Region
8.1.2 Asia Pacific Tapentadol Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Tapentadol Market Facts & Figures by Type
8.3 Asia Pacific Tapentadol Market Facts & Figures by Application

9 Latin America
9.1 Latin America Tapentadol by Country
9.1.1 Latin America Tapentadol Sales by Country
9.1.2 Latin America Tapentadol Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Tapentadol Market Facts & Figures by Type
9.3 Central & South America Tapentadol Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Tapentadol by Country
10.1.1 Middle East and Africa Tapentadol Sales by Country
10.1.2 Middle East and Africa Tapentadol Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Tapentadol Market Facts & Figures by Type
10.3 Middle East and Africa Tapentadol Market Facts & Figures by Application

11 Company Profiles
11.1 Johnson & Johnson Pharmaceutical Research & Development
11.1.1 Johnson & Johnson Pharmaceutical Research & Development Corporation Information
11.1.2 Johnson & Johnson Pharmaceutical Research & Development Description and Business Overview
11.1.3 Johnson & Johnson Pharmaceutical Research & Development Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Pharmaceutical Research & Development Tapentadol Products Offered
11.1.5 Johnson & Johnson Pharmaceutical Research & Development Related Developments
11.2 IPCA Laboratories
11.2.1 IPCA Laboratories Corporation Information
11.2.2 IPCA Laboratories Description and Business Overview
11.2.3 IPCA Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.2.4 IPCA Laboratories Tapentadol Products Offered
11.2.5 IPCA Laboratories Related Developments
11.3 Lupin Laboratories
11.3.1 Lupin Laboratories Corporation Information
11.3.2 Lupin Laboratories Description and Business Overview
11.3.3 Lupin Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Lupin Laboratories Tapentadol Products Offered
11.3.5 Lupin Laboratories Related Developments
11.4 Ranbaxy Laboratories
11.4.1 Ranbaxy Laboratories Corporation Information
11.4.2 Ranbaxy Laboratories Description and Business Overview
11.4.3 Ranbaxy Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ranbaxy Laboratories Tapentadol Products Offered
11.4.5 Ranbaxy Laboratories Related Developments
11.5 Aristo Pharmaceuticals
11.5.1 Aristo Pharmaceuticals Corporation Information
11.5.2 Aristo Pharmaceuticals Description and Business Overview
11.5.3 Aristo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Aristo Pharmaceuticals Tapentadol Products Offered
11.5.5 Aristo Pharmaceuticals Related Developments
11.6 Cadila Pharmaceuticals
11.6.1 Cadila Pharmaceuticals Corporation Information
11.6.2 Cadila Pharmaceuticals Description and Business Overview
11.6.3 Cadila Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Cadila Pharmaceuticals Tapentadol Products Offered
11.6.5 Cadila Pharmaceuticals Related Developments
11.7 Tirupati Medicare
11.7.1 Tirupati Medicare Corporation Information
11.7.2 Tirupati Medicare Description and Business Overview
11.7.3 Tirupati Medicare Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Tirupati Medicare Tapentadol Products Offered
11.7.5 Tirupati Medicare Related Developments
11.1 Johnson & Johnson Pharmaceutical Research & Development
11.1.1 Johnson & Johnson Pharmaceutical Research & Development Corporation Information
11.1.2 Johnson & Johnson Pharmaceutical Research & Development Description and Business Overview
11.1.3 Johnson & Johnson Pharmaceutical Research & Development Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Pharmaceutical Research & Development Tapentadol Products Offered
11.1.5 Johnson & Johnson Pharmaceutical Research & Development Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Tapentadol Market Estimates and Projections by Region
12.1.1 Global Tapentadol Sales Forecast by Regions 2021-2026
12.1.2 Global Tapentadol Revenue Forecast by Regions 2021-2026
12.2 North America Tapentadol Market Size Forecast (2021-2026)
12.2.1 North America: Tapentadol Sales Forecast (2021-2026)
12.2.2 North America: Tapentadol Revenue Forecast (2021-2026)
12.2.3 North America: Tapentadol Market Size Forecast by Country (2021-2026)
12.3 Europe Tapentadol Market Size Forecast (2021-2026)
12.3.1 Europe: Tapentadol Sales Forecast (2021-2026)
12.3.2 Europe: Tapentadol Revenue Forecast (2021-2026)
12.3.3 Europe: Tapentadol Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Tapentadol Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Tapentadol Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Tapentadol Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Tapentadol Market Size Forecast by Region (2021-2026)
12.5 Latin America Tapentadol Market Size Forecast (2021-2026)
12.5.1 Latin America: Tapentadol Sales Forecast (2021-2026)
12.5.2 Latin America: Tapentadol Revenue Forecast (2021-2026)
12.5.3 Latin America: Tapentadol Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Tapentadol Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Tapentadol Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Tapentadol Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Tapentadol Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Tapentadol Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tapentadol Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Johnson & Johnson Pharmaceutical Research & Development、IPCA Laboratories、Lupin Laboratories、Ranbaxy Laboratories、Aristo Pharmaceuticals、Cadila Pharmaceuticals、Tirupati Medicare

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のタペンタドール市場2026:インサイト・予測(Global Tapentadol Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。